Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients

Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands
Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients ( Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands )
14 Dec 2021

Clinical utility of molecular tumour profiling in breast cancer

Prof Fabrice André - Gustave Roussy, Paris, France
Clinical utility of molecular tumour profiling in breast cancer ( Prof Fabrice André - Gustave Roussy, Paris, France )
13 Dec 2021

Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diffuse large B-cell lymphoma.

Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy
Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail patients with diffuse large B-cell lymphoma. ( Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy )
11 Dec 2021

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patients

Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA
Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patients ( Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA )
11 Dec 2021

Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies

Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )
11 Dec 2021

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma ( Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA )
11 Dec 2021

Latest in advanced endometrial cancer

Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote
Latest in advanced endometrial cancer ( Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace Vergote )
9 Dec 2021

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Dec 2021

Post-HSCT management of ALL - Adult ALL perspective

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Post-HSCT management of ALL - Adult ALL perspective ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
6 Dec 2021

Latest in diagnostics in EGFR mutated NSCLC

Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA
Latest in diagnostics in EGFR mutated NSCLC ( Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA )
3 Dec 2021

The Lancet Commission on women and cancer

Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg - International Agency for Research on Cancer, New York, USA
The Lancet Commission on women and cancer ( Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg - International Agency for Research on Cancer, New York, USA )
3 Dec 2021

Palliative care and strategies for screening and early detection in Africa

Dr Miriam Mutebi - Aga Khan University, Nairobi, Kenya
Palliative care and strategies for screening and early detection in Africa ( Dr Miriam Mutebi - Aga Khan University, Nairobi, Kenya )
22 Nov 2021